Dehydrocorydaline chloride
Dehydrocorydaline chloride Basic information
- Product Name:
- Dehydrocorydaline chloride
- Synonyms:
-
- Dehydrocorydaline chloride
- Dehydrocorydaline chloride, 99.95%
- 13-Methylpalmatine chloride
- inhibit,Bcl-2 Family,Dehydrocorydaline chloride,Autophagy,PARP,poly ADP ribose polymerase,Caspase,13-Methylpalmatine,Dehydrocorydaline,p38 MAPK,Parasite,Inhibitor
- 2,3,9,10-Tetramethoxy-13-methyl-5,6-dihydroisoquinolino[3,2-a]isoquinolin-7-ium chloride
- Dehydrocorydaline chloride, 10 mM in DMSO
- CAS:
- 10605-03-5
- MF:
- C22H24ClNO4
- MW:
- 401.88326
- Mol File:
- 10605-03-5.mol
Dehydrocorydaline chloride Chemical Properties
- Melting point:
- 191-193 °C (decomp)
- storage temp.
- Store at -20°C
- solubility
- DMSO: 20 mg/ml
- form
- A solid
- color
- Light yellow to yellow
Dehydrocorydaline chloride Usage And Synthesis
Uses
Dehydrocorydaline chloride (13-Methylpalmatine chloride) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline chloride elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline chloride shows strong anti-malarial effects (IC50?=38 nM), and low cytotoxicity (cell viability?>?90%) using P. falciparum 3D7 strain[3].
Biological Activity
Dehydrocorydaline chloride (13-Methylpalmatine chloride) is an alkaloid isolated from the traditional Chinese medicine Corydalis yanhusuo. It regulates Bax, Bcl-2 protein expression; activates caspase-7, caspase-8, and inactivates PARP. Also Dehydrocorydaline chloride can enhance the activation of p38 MAPK and has anti-inflammatory and anti-cancer effects. .
in vitro
Dehydrocorydaline significantly inhibits MCF-7 cell proliferation in a dose-dependent manner, which can be reversed by a caspase-8 inhibitor, Z-IETD-FMK. Dehydrocorydaline increases DNA fragments without affecting ΔΨm. Western blotting assay shows that dehydrocorydaline dose-dependently increases Bax protein expression and decreases Bcl-2 protein expression.
in vivo
Dehydrocorydaline (3.6, 6 or 10 mg/kg, ip) shows a dose-dependent anticiceptive effect in the acetic acid-induced writhing test and significantly attenuates the formalin-induced pain responses in mice. In the formalin test , dehydrocorydaline decreases the expression of caspase 6 (CASP6), TNF-α, IL-1β and IL-6 proteins in the spinal cord. These findings confirm that Dehydrocorydaline has antinociceptive effects in mice.
target
p38 MAPK
IC 50
Plasmodium
References
[1] Xu Z, et al. Dehydrocorydaline inhibits breast cancer cells proliferation by inducing apoptosis in MCF-7 cells. Am J Chin Med. 2012;40(1):177-85. DOI:10.1142/S0192415X12500140
[2] Yoo M, et al. Dehydrocorydaline promotes myogenic differentiation via p38 MAPK activation. Mol Med Rep. 2016 Oct;14(4):3029-36. DOI:10.3892/mmr.2016.5653
[3] Nonaka M, et al. Screening of a library of traditional Chinese medicines to identify anti-malarial compounds and extracts. Malar J. 2018 Jun 25;17(1):244. DOI:10.1186/s12936-018-2392-4
[4] Yin ZY, et al. Antinociceptive effects of dehydrocorydaline in mouse models of inflammatory pain involve the opioid receptor and inflammatory cytokines. Sci Rep. 2016 Jun 7;6:27129 DOI:10.1038/srep27129
Dehydrocorydaline chlorideSupplier
- Tel
- 021-58955995
- sales@medchemexpress.cn
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 010-50973130 18101056239
- 3193328036@qq.com
- Tel
- 010-60605840 18892239720
- psaitong@jm-bio.com
- Tel
- +1-800-259-7612
- info@musechem.com